Last update 21 Nov 2024

[68Ga]NODAGA-RGD

Overview

Basic Info

Drug Type
Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals
Synonyms
Target
αvβ3
Mechanism
αvβ3 antagonists(Integrin alpha-V/beta-3 antagonists), PET imaging(Positron-emission tomography enhancers)
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesOther Diseases
Active Indication
Carotid Artery DiseasesInflammationPlaque, Atherosclerotic
Inactive Indication-
Originator Organization
Medical University of InnsbruckMedical University of Innsbruck
Active Organization
Centre Hospitalier Universitaire VaudoisCentre Hospitalier Universitaire Vaudois
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

2
Clinical Trials associated with [68Ga]NODAGA-RGD
EUCTR2014-004392-23-FI / Not yet recruitingPhase 2IIT
68Ga-NODAGA-RGD cardiac PET in patients with acute myocardial infarction or chronic total coronary occlusion
NCT01608516 / RecruitingPhase 1/2IIT
Multimodal Assessment of the Inflammatory Atheromatous Plaque : Comparison Between 68Ga-NODAGA-RGD PET/CT, 18F-FDG PET/CT, MRI AND US
100 Clinical Results associated with [68Ga]NODAGA-RGD
Login to view more data
100 Translational Medicine associated with [68Ga]NODAGA-RGD
Login to view more data
100 Patents (Medical) associated with [68Ga]NODAGA-RGD
Login to view more data
100 Deals associated with [68Ga]NODAGA-RGD
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Carotid Artery DiseasesPhase 2
CH
Centre Hospitalier Universitaire VaudoisCentre Hospitalier Universitaire Vaudois
01 Apr 2012
InflammationPhase 2
CH
Centre Hospitalier Universitaire VaudoisCentre Hospitalier Universitaire Vaudois
01 Apr 2012
Plaque, AtheroscleroticPhase 2
CH
Centre Hospitalier Universitaire VaudoisCentre Hospitalier Universitaire Vaudois
01 Apr 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free